Embecta (EMBC) Income from Continuing Operations (2020 - 2026)
Embecta recorded quarterly Income from Continuing Operations of 4100000.0 in Q1 2026, down 109.3% quarter-over-quarter from 44100000.0 in Q4 2025, and down 117.45% year-over-year from 23500000.0 in Q1 2025.
Embecta's Income from Continuing Operations history runs 7 years deep, the most recent figure standing at 4100000.0 for Q1 2026.
- In Q1 2026, Income from Continuing Operations fell 117.45% year-over-year to 4100000.0; the TTM figure through Mar 2026 stood at 111900000.0 (up 111.93% YoY), while the FY2025 annual figure was 95400000.0, up 21.84% from the prior year.
- Income from Continuing Operations came in at 4100000.0 for Q1 2026 at Embecta, down from 44100000.0 in the prior quarter.
- In the past five years, Income from Continuing Operations ranged from a high of 79600000.0 in Q1 2022 to a low of 17200000.0 in Q3 2022.
- A 5-year average of 25556250.0 and a median of 21800000.0 in 2023 frame the typical range for Income from Continuing Operations.
- Across the five-year window, Income from Continuing Operations tumbled 117.75% in 2022 and jumped 209.52% in 2025, its largest moves.
- Embecta's Income from Continuing Operations stood at 35200000.0 in 2022, then plunged by 42.9% to 20100000.0 in 2023, then slipped by 27.36% to 14600000.0 in 2024, then jumped by 202.05% to 44100000.0 in 2025, then tumbled by 109.3% to 4100000.0 in 2026.
- According to Business Quant data, Income from Continuing Operations over the past three periods registered 4100000.0, 44100000.0, and 26400000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn | 826.00 Mn |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn | -37.00 Mn |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn | 398.73 Mn |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn | 135.40 Mn |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn | 13.00 Mn |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn | 130.80 Mn |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn | 112.77 Mn |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn | -17.00 Mn |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn | 72.77 Mn |
| 10 | Embecta | 197.17 Mn | 3.77 Mn | 127.80 Mn | -4.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.10 Mn |
| Dec 31, 2025 | 44.10 Mn |
| Sep 30, 2025 | 26.40 Mn |
| Jun 30, 2025 | 45.50 Mn |
| Mar 31, 2025 | 23.50 Mn |
| Sep 30, 2024 | 14.60 Mn |
| Jun 30, 2024 | 14.70 Mn |
| Mar 31, 2024 | 28.90 Mn |
| Dec 31, 2023 | 20.10 Mn |
| Sep 30, 2023 | 6.00 Mn |
| Jun 30, 2023 | 15.20 Mn |
| Mar 31, 2023 | 14.00 Mn |
| Dec 31, 2022 | 35.20 Mn |
| Sep 30, 2022 | -17.20 Mn |
| Jun 30, 2022 | 62.40 Mn |
| Mar 31, 2022 | 79.60 Mn |
| Dec 31, 2021 | 98.80 Mn |
| Sep 30, 2021 | 96.90 Mn |
| Jun 30, 2021 | 104.70 Mn |
| Mar 31, 2021 | 107.90 Mn |
| Dec 31, 2020 | 105.30 Mn |